Views & Analysis Imparare a convivere con la LHON Ogni paziente affronta il viaggio della vita a modo proprio, imparando a conoscere la malattia al meglio delle proprie possibilità e attraverso gli strumenti a disposizione.
News EU clears first drug therapy for rare disease cALD Neuraxpharm and Minoryx' Nezglyal has become the first approved drug therapy in the EU for rare neurodegenerative disease cALD.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.